Building clinical trials capacity for tuberculosis drugs in high-burden countries

dc.contributor	Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY, USA; Campaign for Access to Essential Medicines, Médecins Sans Frontières, Geneva, Switzerland; Clinical Trial Division, International Union Against Tuberculosis and Lung Disease, Paris, France; European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa; Center for TB Research, Johns Hopkins University, Baltimore, MD, USA
dc.creator	Schluger, N
dc.creator	Karunakara, U
dc.creator	Lienhardt, C
dc.creator	Nyirenda, T E
dc.creator	Chaisson, R
dc.date	2007-11-06
dc.date.accessioned	2017-01-31T07:11:33Z
dc.date.available	2017-01-31T07:11:33Z
dc.identifier	PLoS Med 2007;4(11):e302
dc.identifier	1549-1676
dc.identifier	17988170
dc.identifier	10.1371/journal.pmed.0040302
dc.identifier	http://hdl.handle.net/10144/30095
dc.identifier	http://fieldresearch.msf.org/msf/handle/10144/30095
dc.identifier	PLoS Medicine
dc.identifier.uri	http://dspace.mediu.edu.my:8181/xmlui/handle/10144/30095
dc.language	en
dc.rights	Published by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permission
dc.title	Building clinical trials capacity for tuberculosis drugs in high-burden countries
dc.type	Article

Files in this item

Files	Size	Format	View
There are no files associated with this item.